NYSE:MDT - Medtronic Stock Price, News, & Analysis

Medtronic trades on the New York Stock Exchange (NYSE) under the ticker symbol "MDT."

Medtronic announced a quarterly dividend on Friday, August 24th. Stockholders of record on Friday, September 28th will be given a dividend of $0.50 per share on Friday, October 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.17%. The ex-dividend date is Thursday, September 27th. View Medtronic's Dividend History.

Medtronic announced that its board has approved a stock buyback program on Thursday, October 5th 2017, which allows the company to buyback $5,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 49% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Medtronic PLC (NYSE:MDT) posted its quarterly earnings results on Tuesday, November, 20th. The medical technology company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.15 by $0.07. The medical technology company had revenue of $7.48 billion for the quarter, compared to the consensus estimate of $7.35 billion. Medtronic had a net margin of 10.56% and a return on equity of 12.98%. The company's quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.07 earnings per share. View Medtronic's Earnings History.

Medtronic updated its third quarter earnings guidance on Tuesday, November, 20th. The company provided earnings per share (EPS) guidance of $1.23-1.25 for the period. Medtronic also updated its FY 2019 guidance to $5.10-5.15 EPS.

20 equities research analysts have issued 12-month price objectives for Medtronic's shares. Their forecasts range from $80.00 to $120.00. On average, they expect Medtronic's stock price to reach $102.4474 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price. View Analyst Price Targets for Medtronic.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Medtronic in the last year. There are currently 7 hold ratings, 12 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Medtronic.

Press coverage about MDT stock has trended somewhat positive this week, according to InfoTrie. The research group rates the sentiment of media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Medtronic earned a media sentiment score of 1.1 on InfoTrie's scale. They also gave news coverage about the medical technology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next few days.

Some companies that are related to Medtronic include Varian Medical Systems (VAR), SONOVA Hldg AG/ADR (SONVY), LivaNova (LIVN), Masimo (MASI), GETINGE AB/ADR (GNGBY), NxStage Medical (NXTM), CONMED (CNMD), Natus Medical (BABY), AxoGen (AXGN), Viewray (VRAY), Cutera (CUTR), Rockwell Medical (RMTI), Semler Scientific (SMLR), BioLife Solutions (BLFS) and Electrocore (ECOR).

Medtronic's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.21%), Massachusetts Financial Services Co. MA (4.25%), Franklin Resources Inc. (2.08%), Dodge & Cox (1.31%), Bank of New York Mellon Corp (1.26%) and Wells Fargo & Company MN (0.94%). Company insiders that own Medtronic stock include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hoedt Rob Ten, Hooman Hakami, James T Lenehan, Michael J Coyle, Omar Ishrak, Richard H Anderson, Richard Kuntz and Robert C Pozen. View Institutional Ownership Trends for Medtronic.

MDT stock was sold by a variety of institutional investors in the last quarter, including Franklin Resources Inc., Capital Research Global Investors, Mitsubishi UFJ Trust & Banking Corp, The Manufacturers Life Insurance Company , Sanders Capital LLC, Dodge & Cox, Massachusetts Financial Services Co. MA and Wells Fargo & Company MN. Company insiders that have sold Medtronic company stock in the last year include Bradley E Lerman, Bryan C Hanson, Carol A Surface, Geoffrey Martha, Hooman Hakami, James T Lenehan, Michael J Coyle and Richard Kuntz. View Insider Buying and Selling for Medtronic.

MDT stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Nordea Investment Management AB, Pendal Group Ltd, Renaissance Technologies LLC, Man Group plc, American Century Companies Inc., FMR LLC and HealthCor Management L.P.. Company insiders that have bought Medtronic stock in the last two years include James T Lenehan, Richard H Anderson and Robert C Pozen. View Insider Buying and Selling for Medtronic.

Shares of MDT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MDT stock can currently be purchased for approximately $92.16.

Medtronic has a market capitalization of $126.54 billion and generates $29.95 billion in revenue each year. The medical technology company earns $3.10 billion in net income (profit) each year or $4.77 on an earnings per share basis. Medtronic employs 86,000 workers across the globe.

The official website for Medtronic is http://www.medtronic.com.

Medtronic's mailing address is 20 ON HATCH LOWER HATCH STREET, DUBLIN L2, D02. The medical technology company can be reached via phone at 353-1438-1700 or via email at [email protected]